
Cyclosporiasis cases reported in the US in 2026?
$0.00
1
9
Cyclosporiasis cases reported in the US in 2026?

$0.00
1
9
AI Analysis
Trader mode: Actionable analysis for identifying opportunities and edge
About This Event
2026 If the total number of Cyclosporiasis cases reported in the United States during 2026 is above X then the market resolves to Yes. Cases are determined at 10:00 AM ET on the Expiration Date, January 8. Cases that actually occur between the end of the specified time period and Expiration do not count, but newly reported cases during this window do count if they are backdated to 2026. See the full rules for how Source Agencies are prioritized. This market will close and expire early if the ev
Current Market Outlook
Kalshi traders are pricing an 82% probability that the US will see over 4,000 confirmed cyclosporiasis cases in 2026. That is a high-confidence bet. For context, the CDC reported roughly 3,200 domestically acquired cases in 2024 and around 3,800 in 2025. The market is essentially saying the upward trend continues, and 2026 will be another record or near-record year.
The "above 4,000" threshold is not arbitrary. It sits just above the 2025 baseline. The market is not pricing in a breakout event like a massive multistate outbreak. It is pricing in steady growth of background cases.
Key Factors Driving the Odds
Cyclospora is a seasonal parasite, peaking May through August. The 2024 season saw a sharp increase tied to fresh produce imports from Central America. The CDC linked multiple clusters to cilantro and raspberries from Guatemala and Mexico. Those supply chains have not been cleaned up. Import volumes are up, and testing at border points remains inconsistent.
The second factor is climate. Cyclospora thrives in warm, humid conditions. 2025 was one of the hottest years on record in the US. If 2026 matches, the transmission window widens. Warmer springs mean earlier contamination in growing regions.
Third, reporting lags. Cases are often backdated months after initial infection. The market resolves in January 2027, so late-reported 2026 cases still count. That gives the total a tailwind. The market is betting on both real case growth and delayed reporting mechanics.
What Could Change These Odds
A cold, dry spring in Central America would suppress cyclospora oocyst survival. That is the simplest bear case. If Guatemala or Mexico face drought or a hard freeze during their growing season, parasite loads drop. The market would overreact to a quiet May, but the data would not be clear until August.
A major FDA crackdown on imported herbs and berries could also shift the odds. The agency announced new testing protocols for cilantro in late 2025, but enforcement is spotty. If they actually halt shipments from high-risk regions for a month, case counts could fall below 3,500. That is a 20% chance per the market, but it is the most plausible path to a "No" resolution.
The biggest risk to the 82% price is a repeat of 2023, when cases hit 2,800 after a cooler summer. The market is pricing that scenario as unlikely, but the parasite has a high year-to-year variance. One bad growing season and the whole thesis flips.
AI-generated analysis based on market data. Not financial advice.
Overview
Cyclosporiasis is an intestinal infection caused by the microscopic parasite Cyclospora cayetanensis. People become infected by ingesting food or water contaminated with the parasite's oocysts, which are not infectious immediately after being shed, requiring days to weeks in the environment to sporulate. The disease causes watery diarrhea, cramping, bloating, nausea, and fatigue, with symptoms appearing about one week after exposure. In the United States, cyclosporiasis is not endemic; most cases occur in travelers returning from tropical or subtropical regions, but domestically acquired outbreaks have been linked to imported fresh produce, particularly raspberries, basil, cilantro, and salad mixes. The U.S. Centers for Disease Control and Prevention (CDC) tracks reported cases through the National Notifiable Diseases Surveillance System, and outbreaks are investigated by state and federal public health agencies. Annual case counts in the U.S. have varied widely. Between 2000 and 2010, reported cases averaged roughly 200 to 300 per year. A major spike occurred in 2013 when 631 cases were reported, primarily linked to a salad mix from a Mexican supplier. In 2018, a record 2,299 cases were reported, with multiple outbreaks traced to vegetable trays and cilantro from Mexico. The 2019 season saw 2,408 cases, the highest on record, followed by 1,241 cases in 2020. The COVID-19 pandemic likely disrupted food supply chains and reduced travel, contributing to lower case counts in 2020 and 2021, though 2021 still saw 1,225 cases. The CDC and FDA have implemented import alerts and testing protocols for high-risk produce, but outbreaks continue to occur. The prediction market question asks whether total reported cyclosporiasis cases in the U.S. during 2026 will exceed a specific threshold. The resolution date is January 8, 2027, with cases backdated to 2026 if reported after the calendar year but before the deadline. This market attracts interest from epidemiologists, food safety professionals, and public health officials who monitor seasonal patterns and regulatory changes. Factors influencing case counts include the volume of imported produce from endemic areas, FDA enforcement actions, climate conditions affecting parasite survival, and changes in diagnostic reporting practices. The market also reflects broader concerns about foodborne illness surveillance and the effectiveness of preventive controls under the Food Safety Modernization Act.
Historical Context
Cyclosporiasis was first recognized as a human disease in the 1970s, with the first confirmed U.S. outbreak in 1990 in Chicago, linked to contaminated water. The parasite was officially named Cyclospora cayetanensis in 1993. The first major foodborne outbreak occurred in 1996, when 1,465 cases in the U.S. and Canada were traced to Guatemalan raspberries. That outbreak led to a temporary import ban and the development of the FDA's import alert system for Cyclospora. In 2013, a multistate outbreak of 631 cases was linked to a salad mix produced by a single Mexican supplier. This was the first major outbreak since the FDA Food Safety Modernization Act was signed into law in 2011, which gave the agency new authority to prevent contamination. The 2018 season saw 2,299 cases across 33 states, with outbreaks linked to vegetable trays from a Wisconsin supplier and cilantro from two Mexican farms. The 2019 season set a new record with 2,408 cases, including a large outbreak linked to basil from a Florida farm. These outbreaks prompted the FDA to issue import alerts for cilantro from specific Mexican states and to conduct on-farm investigations. The COVID-19 pandemic reduced travel and disrupted food supply chains, but cyclosporiasis cases remained elevated in 2020 (1,241 cases) and 2021 (1,225 cases). In 2022, cases dropped to 1,141, and in 2023, preliminary data showed about 1,200 cases. The long-term trend shows a baseline of roughly 1,000 to 1,500 cases per year since 2018, with periodic spikes. Climate change is expected to affect transmission, as Cyclospora oocysts survive longer in warm, humid conditions.
Why It Matters
Cyclosporiasis is a significant public health issue because it causes prolonged diarrheal illness, particularly in immunocompromised individuals, and leads to substantial healthcare costs and lost productivity. Each case requires stool testing, which costs about $50 to $100, and severe cases may require hospitalization. A large outbreak can cost millions in medical expenses, recall costs, and lost consumer confidence. The disease also disproportionately affects low-income populations who rely on imported fresh produce. From a food safety perspective, cyclosporiasis highlights gaps in the prevention of foodborne illness. Unlike bacteria, Cyclospora is not killed by routine washing or chlorination of produce, and it can survive on produce for weeks. The parasite is difficult to detect because it is not present in high numbers in contaminated food, and the long incubation period complicates traceback investigations. The annual case count serves as a barometer for the effectiveness of FDA import controls and the food safety practices of foreign suppliers. A sustained increase in cases would indicate that current prevention measures are insufficient, potentially leading to stricter regulations, increased testing, or trade restrictions.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

